Parents' Experience With a Mobile Health Intervention to Influence Human Papillomavirus Vaccination Decision Making: Mixed Methods Study.
Parents' Experience With a Mobile Health Intervention to Influence Human Papillomavirus Vaccination Decision Making: Mixed Methods Study.
复制标题
DOI：
10.2196/30340
复制
发表时间：
2022-02-21
影响因子：
3.7
通讯作者：
Vernon SW
中科院分区：
文献类型：
--
作者：
Becker ER;Shegog R;Savas LS;Frost EL;Coan SP;Healy CM;Spinner SW;Vernon SW
人乳头瘤病毒（HPV）引起的癌症是可以预防的，但HPV疫苗接种率严重落后于其他青少年疫苗接种。HPVcancerFree（HPVCF）是一种移动的健康（mHealth）干预措施，旨在通过提高对HPV的认识来影响父母的HPV疫苗接种决策，减少HPV疫苗接种障碍，并通过智能手机应用程序实现HPV疫苗接种计划和提醒。评估mHealth干预措施的用户体验是评估其质量和成功的重要组成部分，但在mHealth干预措施评估中往往被低估。我们的目的是评估HPVCF的用户体验，这是一款为儿科诊所网络设计的HPV癌症预防应用程序，使用从日志文件、调查措施和定性反馈中收集的混合方法数据。研究数据来自美国一个大型儿科诊所网络的父母，在一项分组随机对照试验的治疗研究条件下使用HPVCF进行评价。记录HPVCF保留和使用的数据。干预后评定量表和项目评估HPVCF效用，有用性，可理解性，吸引力，可信度和感知影响。使用移动的应用程序评定量表（uMars）的用户版本评价总体质量。开放式答复评估了父母对HPVCF增强的建议。98名父母主要是女性（n=94，96%），41（5.67）岁，受过大学教育（n=55，56%），白色和非西班牙裔（n=55，56%），并为他们的孩子提供私人健康保险（n=75，77%）。父母使用HPVCF 197次，平均访问时间约为3.5分钟。uMARS应用程序质量评分为正偏态（4.2/5.0）。信息的平均评分最高（4.46 [SD 0.53]），参与度最低（3.74 [SD 0.69]）。此外，在95名父母中，45名（47%）认为HPVCF有助于HPV疫苗接种决策，16名（17%）将HPV疫苗接种归因于HPVCF。父母报告说，HPVCF提高了他们的认识（84/95，88%），知识（84/95，88%）和HPV疫苗接种意向（64/95，67%）。98名父母中的大多数将4种HPVCF组分评定为有用（72-92 [73%-94%]）。父母也同意HPVCF是明确的（86/95，91%），准确的（86/95，91%），比他们收到的其他HPV疫苗信息更有帮助（89/95，94%），他们会推荐给其他人（81/95，85%）。此外，家长们还提出了提高对该应用程序的认识和参与度的方法，沿着增强内容和功能的机会。HPVCF深受家长欢迎，在质量、有用性、实用性、可信度和感知影响等指标上表现良好。本研究为越来越多的文献提供了多方法和多措施评估，这些文献专注于评估以患者为中心的技术介导的HPV教育应用程序的用户体验。
Human papillomavirus (HPV)-attributed cancers are preventable, yet HPV vaccination rates severely lag behind other adolescent vaccinations. HPVcancerFree (HPVCF) is a mobile health (mHealth) intervention developed to influence parental HPV vaccination decision making by raising awareness of HPV, reducing HPV vaccination barriers, and enabling HPV vaccination scheduling and reminders through a smartphone app. Evaluating the user experience of mHealth interventions is a vital component in assessing their quality and success but tends to be underreported in mHealth intervention evaluation. We aimed to evaluate the user experience of HPVCF, an HPV cancer prevention app designed for a pediatric clinic network, using mixed methods data collected from log files, survey measures, and qualitative feedback. Study data were evaluated from parents in a large US pediatric clinic network using HPVCF in the treatment study condition of a group randomized controlled trial. Log data captured HPVCF retention and use. Postintervention rating scales and items assessed HPVCF utility, usefulness, understandability, appeal, credibility, and perceived impact. Overall quality was evaluated using the user version of the Mobile Application Rating Scale (uMars). Open-ended responses assessed parent recommendations for HPVCF enhancement. The 98 parents were mainly female (n=94, 96%), 41 (5.67) years of age, college educated (n=55, 56%), and White and non-Hispanic (n=55, 56%) and had private health insurance for their children (n=75, 77%). Parents used HPVCF 197 times, with the average visit duration approximating 3.5 minutes. The uMARS app quality score was positively skewed (4.2/5.0). Mean ratings were highest for information (4.46 [SD 0.53]) and lowest for engagement (3.74 [SD 0.69]). In addition, of 95 parents, 45 (47%) rated HPVCF as helpful in HPV vaccination decision making and 16 (17%) attributed HPV vaccine initiation to HPVCF. Parents reported that HPVCF increased their awareness (84/95, 88%), knowledge (84/95, 88%), and HPV vaccination intentions (64/95, 67%). Most of the 98 parents rated the 4 HPVCF components as useful (72-92 [73%-94%]). Parents also agreed that HPVCF is clear (86/95, 91%), accurate (86/95, 91%), and more helpful than other HPV vaccine information they had received (89/95, 94%) and that they would recommend it to others (81/95, 85%). In addition, parents suggested ways to increase awareness and engagement with the app, along with opportunities to enhance the content and functionality. HPVCF was well received by parents and performed well on indicators of quality, usefulness, utility, credibility, and perceived impact. This study contributes a multimethod and multimeasure evaluation to the growing body of literature focused on assessing the user experience of patient-focused technology-mediated applications for HPV education.